Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Allergy Thera. (AGY) Regulatory News

Date Source Headline
16th Mar 2018 12:53 pm RNS Director/PDMR Shareholding
7th Mar 2018 9:30 am RNS Hardman: Clinical development towards submission
7th Mar 2018 7:00 am RNS Interim Results
28th Feb 2018 7:00 am RNS Polyvac® Peanut CMO appointed
12th Feb 2018 7:00 am RNS Completion of recruitment in PQ Grass Ph II trial
2nd Feb 2018 7:15 am RNS Hardman Research: Growth in a tough market
31st Jan 2018 7:00 am RNS Trading Update
10th Jan 2018 3:19 pm RNS Holdings in Company
9th Jan 2018 7:00 am RNS PQ Birch Phase III trial completes recruitment
12th Dec 2017 7:00 am RNS Co-development agreement with Ergomed plc
7th Dec 2017 5:08 pm RNS Holding(s) in Company
22nd Nov 2017 11:36 am RNS Result of AGM
21st Nov 2017 7:00 am RNS Block Listing Application
13th Nov 2017 7:00 am RNS Allergy Therapeutics to Present at Jefferies 2017
7th Nov 2017 12:59 pm RNS Director/PDMR Shareholding
7th Nov 2017 11:54 am RNS Director/PDMR Shareholding
19th Oct 2017 4:14 pm RNS Publication of Annual Report and notice of AGM
19th Oct 2017 7:00 am RNS Commencement of dosing in PQ Grass Phase II Trial
12th Oct 2017 5:39 pm RNS Holding(s) in Company
12th Oct 2017 2:55 pm RNS Director/PDMR Shareholding
10th Oct 2017 7:15 am RNS Hardman Research: Continuing to gain market share
28th Sep 2017 7:00 am RNS Preliminary Results
18th Sep 2017 7:00 am RNS Approval for PQ Grass Phase II trial
11th Sep 2017 7:00 am RNS Expansion of Clinical Development and R&D teams
15th Aug 2017 7:00 am RNS Notice of Results
18th Jul 2017 7:00 am RNS Trading Update
6th Jul 2017 7:00 am RNS Publication of adjuvant studies in journals
27th Jun 2017 7:00 am RNS Investor and analyst site visits
19th Jun 2017 7:00 am RNS Satellite Symposium at EAACI 2017
6th Jun 2017 7:00 am RNS Directorate changes
2nd Jun 2017 12:55 pm RNS Holding(s) in Company
13th Apr 2017 7:00 am RNS Issue of Equity
5th Apr 2017 7:15 am RNS Hardman Research: Development across portfolio
29th Mar 2017 7:00 am RNS Interim Results for six months ended 31 Dec 2016
16th Mar 2017 7:00 am RNS First Patient in Pivotal Phase III Birch Study
9th Mar 2017 7:00 am RNS Notice of Interim Results
14th Feb 2017 7:00 am RNS House Dust Mite Allergy Vaccine Gains CTA Approval
8th Feb 2017 7:00 am RNS Directorate Change
1st Feb 2017 7:00 am RNS Positive Efficacy & Safety Data in Peanut Vaccine
20th Jan 2017 7:15 am RNS Hardman Research: Investment driving market share
FTSE 100 Latest
Value10,559.58
Change-49.48